Company / Profit Margin
Caris Life Sciences, Inc. Profit Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-8.4%
FY2025
5-year range
-111.5% / -8.4%
FY2023-FY2025
Trend
+87.7%
vs FY2024
Sector context
#121 of 155
Health Care
What the data says
Caris Life Sciences, Inc.'s profit margin of -8.4% is lower than 78% of companies in the Health Care sector (FY2025). Improved from -111.5% to -8.4% over the past 2 years.
Based on SEC 10-K filings.
-8.4% in FY2025.
Improved from -111.5% to -8.4% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 155This company -8.4% Sector average -254.2%
▼
+96.7% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 87.7% year-over-year.
- Currently 245.8pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -8.4% | +87.7% |
| FY2024 | -68.4% | +38.7% |
| FY2023 | -111.5% | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026